Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function von Ontaneda, Daniel, MD, Thompson, Alan J, Prof, Fox, Robert J, Prof, Cohen, Jeffrey A, Dr Prof

Volltext

Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives von Ontaneda, Daniel, Dr, Fox, Robert J, MD, Chataway, Jeremy, PhD

Volltext

Using serum neurofilament-light in clinical practice: Growing enthusiasm that may need bridling von Lycke, Jan, Fox, Robert J

Volltext

Feast or famine in multiple sclerosis therapeutics von Fox, Robert J

Volltext

Sjögren's syndrome von Fox, Robert I

Volltext

How common is active inflammation in progressive multiple sclerosis? von Fox, Robert J.

Volltext

Treatment of Sjögren’s syndrome: current therapy and future directions von Fox, Robert I., Fox, Carla M., Gottenberg, Jacques Eric, Dörner, Thomas

Volltext

Secondary Progressive Multiple Sclerosis: New Insights von Cree, Bruce A.C., Arnold, Douglas L., Chataway, Jeremy, Chitnis, Tanuja, Fox, Robert J., Pozo Ramajo, Angela, Murphy, Niamh, Lassmann, Hans

Volltext

Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis von Baldassari, Laura E., Fox, Robert J.

Volltext

Imaging as an Outcome Measure in Multiple Sclerosis von Ontaneda, Daniel, Fox, Robert J.

Volltext

Relationship Between Serum Neurofilament Light and Multiple Sclerosis Disability Progression: Clear as Mud von Goldschmidt, Carolyn, Fox, Robert J.

Volltext

Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis von Salter, Amber, Fox, Robert J, Newsome, Scott D, Halper, June, Li, David K. B, Kanellis, Pamela, Costello, Kathleen, Bebo, Bruce, Rammohan, Kottil, Cutter, Gary R, Cross, Anne H

Volltext

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis von Fox, Robert J, Miller, David H, Phillips, J. Theodore, Hutchinson, Michael, Havrdova, Eva, Kita, Mariko, Yang, Minhua, Raghupathi, Kartik, Novas, Mark, Sweetser, Marianne T, Viglietta, Vissia, Dawson, Katherine T

Volltext

Progressive multiple sclerosis von Ontaneda, Daniel, Fox, Robert J

Volltext

T1‐/T2‐weighted ratio differs in demyelinated cortex in multiple sclerosis von Nakamura, Kunio, Chen, Jacqueline T., Ontaneda, Daniel, Fox, Robert J., Trapp, Bruce D.

Volltext

Between-speaker and within-speaker variation in speech tempo of American English von Jacewicz, Ewa, Fox, Robert Allen, Wei, Lai

Volltext

Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study: A Randomized Clinical Trial von Kappos, Ludwig, Fox, Robert J, Burcklen, Michel, Freedman, Mark S, Havrdová, Eva K, Hennessy, Brian, Hohlfeld, Reinhard, Lublin, Fred, Montalban, Xavier, Pozzilli, Carlo, Scherz, Tatiana, D'Ambrosio, Daniele, Linscheid, Philippe, Vaclavkova, Andrea, Pirozek-Lawniczek, Magdalena, Kracker, Hilke, Sprenger, Till

Volltext

Tissue Markers for Acute Multiple Sclerosis Treatment Response—A Step Toward Personalized Medicine von Fox, Robert J

Volltext

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study von Trapp, Bruce D, Vignos, Megan, Dudman, Jessica, Chang, Ansi, Fisher, Elizabeth, Staugaitis, Susan M, Battapady, Harsha, Mork, Sverre, Ontaneda, Daniel, Jones, Stephen E, Fox, Robert J, Chen, Jacqueline, Nakamura, Kunio, Rudick, Richard A

Volltext

Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges von Chataway, Jeremy, Williams, Thomas, Li, Vivien, Marrie, Ruth Ann, Ontaneda, Daniel, Fox, Robert J

Volltext